Originally published January 19 2006
GSK diabetes drugs causing eye problems for some patients
by Mike Adams, the Health Ranger, NaturalNews Editor
The European Medicines Agency reported rare episodes of macular oedema, or swelling at the back of the eye, in patients who used two oral diabetes drugs manufactured by GlaxoSmithKline, and the agency has since determined to conduct an investigation.
European regulators said they were reviewing the safety of two popular oral diabetes drugs following rare case of eye problems that may be associated with the medicines.
The European Medicines Agency said yesterday rare episodes of macular oedema, or swelling of the back of the eye, had been reported with GlaxoSmithKline Plc's Avandia and Takeda Pharmaceutical Co Ltd's Actos.
The agency's Committee for Medicinal Products for Human Use will now carry out a review to establish whether there is a link between macular oedema and the use of the drugs, which belong to a class of diabetes treatments known as glitazones.
The medicines work by making the body's cells more sensitive to insulin, thereby helping people with type II, or adult-onset, diabetes to better use their own natural insulin.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml